chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COPD.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in arm). At the time of the report, PAIN IN EXTREMITY (Pain in arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant included inhalers for COPD  Treatment information was not provided.
Got DTaP and IPV: Right thigh and developed swelling with erythematous rash 6" x 6" with increase local temp. Treated with Tylenol, Benadryl and ice pack.
LeftArm is red and swollen, itchy and painful. more than the typical reaction. Came to see Doctor two days after vaccines given
10 month old received first Pfizer-Biotech 6 month to 4 years 0.2ml IM vaccine in primary series 22 July 2022. Patient received second Pfizer-Biotech 6 month to 4 years 0.2ml IM vaccine in primary series on 2 August 2022. The first vaccine and second vaccine are to close together. Mother of Child on 3 Aug reports patient fussy but no dyspnea, wheezing, vomiting, and angioedema. No changes in eating or drinking.
Dementia patient in skilled nursing facility inadvertently administered 3rd dose in 2 dose series.  First dose 1/12/2021, Second Dose 2/1/2021, Third Dose 2/25/2021
Warm and redf; Itchy; Redness; This case was reported by a pharmacist via call center representative and described the occurrence of feeling of warmth in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th August 2019, the patient received the 1st dose of Shingrix (intramuscular). On 22nd August 2019, 2 days after receiving Shingrix, the patient experienced feeling of warmth, pruritus and erythema. The patient was treated with benadryl (nos) (Benadryl). On an unknown date, the outcome of the feeling of warmth, pruritus and erythema were recovering/resolving.   It was unknown if the reporter considered the feeling of warmth, pruritus and erythema to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was captured as adult as per Shingrix indication.  The patient received vaccine in unknown arm. The patient called on Thursday, that they were having reaction below the injection site. It was warm, red and itching.  The healthcare professional advised the patient to take a Benadryl. The reporter consented to follow up.
Throat swelling shut, difficulty breathing , rapid heart rate, hypertension, dizziness, weakness
After the 15 minute waiting period was up he was breathing deeply with his eyes closed and didn't respond to his timer going off. When I went out to check on him he said he had a sudden onset of chills and sweating, kind of funny feeling. The sweat was visible on his skin (arms & Face). I told him to sit another 10 minutes while we watched him. He was visibly nervous when he arrived and had told me this was his first vaccination in 20 years. After another 10 minutes he said he was feeling  and was ready to leave.
Cancer; This spontaneous case was reported by a patient family member or friend and describes the occurrence of NEOPLASM MALIGNANT (Cancer) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced NEOPLASM MALIGNANT (Cancer) (seriousness criteria death and medically significant). The reported cause of death was Cancer. It is unknown if an autopsy was performed.            It was unknown that patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Concomitant medication details not reported by the reporter.  Suspect vaccine dosage text was reported as unknown.  It was reported that the Moderna Covid-19 caused cancer in 25 patients who were the friends of reporter. The patient will not provide any additional information on these patients. It was also reported that the those patients who died were killed by the Moderna Covid-19 vaccine because Moderna vaccine is poison Cancer rates for jabbed Moderna Cancer patients was up 300% The Doctors are part of the Kabal along with Moderna.  Treatment details was not reported by the reporter.  This case contains information about 5th patient out of 25 patients. Company comment- This is a fatal spontaneous case concerning a patient of unknown gender and age with no medical history reported who experienced the serious (death and medically significant) unexpected event of neoplasm malignant. A dose of mRNA-1273.222 (Original/Omicron BA.4/5) vaccine was administered. Temporal association cannot be assessed due to lack of information on onset date of the event and vaccination date. It is unknown if autopsy was performed. Reporter stated that vaccine caused cancer in 25 patients who are friends of her. No further details were provided for medical review. The benefit-risk relationship of mRNA-1273.222 (Original/Omicron BA.4/5) vaccine is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2023-735987 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735987:Master case, Patient 1; Reported Cause(s) of Death: Cancer
Patient started feeling tingly, tired, woozy, and sweaty.  Immediately laid pt. down.  BP 110/70. Pulse thready @54.  Within 5 minutes color returned and sweating decreased, BP 110/80.  Fully oriented X's3.
Vomited levothyroxin within 15 minutes of taking it on 2 consecutive mornings after receiving 2nd dose. After that no issue. No treatment was sought.
MILD COVID; This spontaneous report received from a consumer via a company representative through social media concerned multiple patients. Initial information was processed along with additional information on 27-DEC-2022. The patient's weight, height, and medical history were not reported. The patients received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose not reported, 1 total administrated on an unspecified date for covid-19 prophylaxis. It was unknown whether patients had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 1). The patients received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose not reported, 1 total administrated on an unspecified date for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date few patients experienced mild covid (dose number in series 2). The reporter stated "not everyone gets it! My family and friends got all vaccines and only a few got mild Covid".  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of mild covid was not reported. This report was non-serious. This report was associated with a product quality complaint.
gross hematuria, new nephrotic syndrome, possible AKI all one-day after receiving 2nd Pfizer vaccine.  Patient has a history of intermittent microscopic hematuria x2 when he was a teenager.
Headache, muscle aches, pain at injection site, cough & fever of 100.1 F Was fever free by 10am 3/17/21
pt recvd vax 21JUN93 pt to MD 29JUN; t105 has been;crying several days, has rash small raised circles; seen & observed by MD to have staggering gait & fall over, stiffens up & then relaxes;
Pt who has a history of varicella as a child and exposure to varicella as a teacher was exposed to her daughter who was vaccinated with one dose of varicella virus vaccine live on 05/13/1999. On 05/23/1999 the pt broke out in rash and was seen by a physician. She was diagnosed with a typical varicella rash. The daughter was reported to be fine, however the child's father was reported to have had a similar experience.
"COVID RASH" on upper left arm near injection site developed 7 days later on 4/5 .  Size about 2" x 3" oval.   Warm and itches.  Discomfort stops with Benadryl Allergy Liqui-Gel 25mg antihistamine.  One week later now 4/8 rash is 95% gone.
Taken by ambulance from home to hospital. Husband reports symptoms to be slurred speech, overall weakness in body, thrashing around in bed. Approx. 6am on 11-18-22. Admitted to hospital for 1 day and did testing. Diagnosis was Ischemic Stroke. Follow up with Primary physician and other specialists.
Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.  No adverse reactions were reported by patient.
This pt & 3 others exp "minor reactions ranging from swelling @ inject site to aches" following the administration of Typhoid vax;
This spontaneous report was received from a nurse referring to a unspecified patients of unknown age and gender. Medical history and current conditions were not reported. On an unknown dates, since 11-DEC-2015, the patients were vaccinated with ZOSTAVAX (dose, frequency, indication, route of administration were not reported, lot # L012478 with expiration date: 10-JUL-2016). The doses of ZOSTAVAX were improperly stored (temperature: 6F for 5 minutes). Concomitant therapy was not reported. No adverse experiences have been reported. This is one of several reports received from the same reporter. Additional information has been requested.
Received injection R deltoid 11/7/05.  Beginning 11/8/05 has had pain on/off in R arm/shoulder since through today.  Did not experience erythema/swelling in shoulder.  Symptoms similar to rotator cuff tendinitis vs tear.
Information has been received from a physician concerning a female with "prior isogtry", who in December 2006, was vaccinated with one dose of Zostavax. "Within the past 2 weeks", on approximately 21-FEB-2007, also reported as 3 months after she received Zostavax the patient developed shingles. Medical attention was sought, it was reported that the physician "had to" administer an antiviral to treat the patient. At the time of the report the patient had not recovered. There was no product quality complaint involved. No further information was provided. The patient's shingles were considered to be an other important important medical event. Additional information has been requested.
This case meets criteria for vaccine breakthrough review. Admitted for fall, endorses no COVID SxS, but known exposures.
No additional adverse effect; expired GARDASIL 9 was inadvertently administered; This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender.  The patient's concurrent conditions, medical history and concomitant medications were not reported.  The pharmacist called to report that an expired dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), lot # R009615, expiration date 07-DEC-2020, (dose, route and anatomical location were not reported) was inadvertently administered to the patient on 12-DEC-2020 for prophylaxis. No additional adverse effect were reported.
Given injection 6/2/04 morning 10.00am. In the evening of 6/3/04 10.00pm developed tenderness at the site. Then on 6/4/04 redness or tenderness at the site of injection. Fatigue, tiredness, fever 100.3F oral, also on 6-9-04.
1 year old shots, including varicella given. 1-2 weeks later a full body rash appeared.
Was ill for approx 9 days with fever, weakness, sore throat, shortness of breath, fatigue. I returned to work on 01/19/22.  I recieved a booster on 10/20/2021 but am not abale to retrieve the Lot number for the injection.
24 hours post vax, the pt experienced injection site redness, pain, swelling and induration.
Mild swelling and soreness at injection site; Mild swelling and soreness at injection site; This is a spontaneous report from a contactable other hcp (patient). A 45-year-old female patient received bnt162b2 (Lot EJ1685), intramuscularly at arm left, first dose on 21Dec2020 16:00, at single dose for COVID-19 immunization. Medical history included diabetes, hypertension, fibromyalgia, morbid obesity and obstructive sleep apnea from an unknown date. Not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's concomitant medications were not reported. The patient experienced mild swelling and soreness at injection site on 21Dec2020 21:00. The events were reported as non-serious. No treatment received. No covid prior vaccination. Since the vaccination, the patient has been tested for COVID-19. Covid test post vaccination included nasal swab on 21Dec2020. Covid test result is negative. The outcome of the event was recovering.
pt became syncopal, diaphoretic, hyporesponsive, hypotonic, pale, hypoventilatory, shocky w/in 1/2 hr of DTP vax this lasted approx 1/2 hr;
Allergic reaction: rash on hands, feet, fingertips, toes, arms, legs, and rim of nostrils. Started 10 days after first dose. Suppressed with oral antihistamines. Ongoing for approximately 2 months so far. No signs of stopping.
Night of the flu shot and following day and that night (9-30 to 10-2) I had severe body aches, fever and headache.  I hardly got out of bed.  Then for the next 2 weeks I've had a low grade fever (99-100.8) and headache constantly.  The last 2 days my fever has gone down slightly (89.5-99.5) but my headache is still bad.  Any time I get up to do something I begin to feel hot and feel worse.  My temp goes up when I am doing anything other than laying down.
Pt recvd 2nd dose of Hep B vax 14DEC88 & devel soreness in left shoulder.On 04JUN89 pt recvd 3rd dose of vax & condition worsened.On 21DEC89 pt dx w/ adhesive capsulitis & probable rotator cuff tendinitis w/ secondary shoulder stiffness.
Associate received first COVID-19 vaccine on January 5, 2021 at another facility within our Health System. Came to our facility 28 days later for second dose of  vaccine. After vaccine given, realized the first dose had been Moderna. Lot # 037K20A No adverse effects - associate did not receive the correct vaccine; talked to associate - no immediate effects, no need to receive further vaccination
Pt had vaccine induced varicella with 21 lesions on face and trunk at different stages of development.
Felt a little bit off; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt a little bit off) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history provided by the reporter.     On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced FEELING ABNORMAL (Felt a little bit off). On 02-Apr-2021, FEELING ABNORMAL (Felt a little bit off) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Apr-2021, Body temperature: 98.9f (Inconclusive) 98.9F.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication include medications for mental health condition (unspecified).  No treatment information reported.   This case was linked to MOD-2021-101542 (Patient Link).
3/5/21 second dose of moderna vacc 3/6/21 fatigue & constitutional sx 3/7/21 aphasia and bazaar behavior
had them twice since two injections/ suspected Vaccination failure; had them twice; hurt; I´m lost, sad, mad, discouraged, depressed; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had shingles 6 times last year).   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: had them twice since two injections/ suspected Vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: had them twice), pain (Verbatim: hurt) and depressive state (Verbatim: I´m lost, sad, mad, discouraged, depressed). The outcome of the vaccination failure was unknown and the outcome of the shingles, pain and depressive state were not reported.   It was unknown if the reporter considered the vaccination failure, shingles, pain and depressive state to be related to Shingles vaccine and Shingles vaccine.   It was unknown if the company considered the vaccination failure, shingles, pain and depressive state to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 09-MAR-2023 This case was reported by a patient via interactive digital media. The patient guessed he/she was the unfortunate one.  The reporter stated that please did not thought this was an exaggeration because he/she was telling you the truth.  The patient had shingles so many times that he/she had lost count.  The patient had shingles six times last year and he/she had shingles twice since he/she had his/her two shingles injections in 2023.  The patient had shingles twice since the last shot. Actually, he/she had shingles as he/she had written.  The patient stated that they hurt and was lost.  The patient was sad, mad, discouraged and depressed. The patient did not know what else could be done.  The patient just wish he/she knew a specialist or what kind of doctor he/she should see. This case was considered as suspected vaccination failure as details time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
severe muscular body aches all over her body especially her legs and back; severe muscular body aches all over her body especially her legs and back; severe muscular body aches all over her body especially her legs and back; This is a spontaneous report from a contactable consumer. A 49-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for Injection, Batch/Lot number: Unknown) via an unspecified route of administration on Jun2021 as DOSE 2, SINGLE (at the age of 49-year-old) for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient received the second dose of the Pfizer COVID-19 vaccine some time in June, exact date unknown. Since June, patient has severe muscular body aches all over her body, especially in her legs and back. Reporter reported that there has been an increase in intensity since July. Patient stands up most of the day to work. The outcome of the events was not resolved.   No further details were provided or obtained.
Ten minutes post 2nd Pfizer vaccine patient complained of chest uneasiness and tachycardia. She also complained of diaphoresis and dizziness.
Systemic: Numbness (specify: facial area, extremities)-Medium, Additional Details: numbness in middle and ring finger on left arm
Mom called on 5-27 and stated child developed rash and fever several days after imm - mom states rash was very bad and on May 23 they took him to ER - Blood work was done and they were told he had German Measles and Chickenpox. Rx for BENADRYL and TYLENOL, states hosp knew he had had imm on the 12th - ask mom to send a copy of ER report and she agreed to but a month later has not sent it. Phone now dc'd. Child was much better when I talked with her a week after 1st contact.
Extreme swelling in upper arm (where injections were given).  Significant muscular pain and stiffness in the arm, neck, back, and chest--significantly more than any other previous vaccinations (lasting 4 days); Large itchy blister like hives on BOTH upper arms.  For the pain, ibuprofen taken during the day and Bayer PM or Tylenol PM taken at bedtime.  For the hives, hydrocortisone cream was applied and oral Benadryl was taken.  Hives were gone by the next day.
The patient came to the pharmacy to receive a Covid vaccine for the pfizer but instead received a flu vaccine.
patient received expired dose of pfizer.  patient was sluggish and drowsy.  patient will not be in for revaccination
Pt passed out after receiving the shot.  The pharmacist helped him to the floor.  He was out for about a minute and seemed to tense up before coming to.  He was confused at first about where he was. It took several minutes for him to get his barring.  He was extreemly slow to recover and his blood pressure bottomed out several times while paramedics were here.  Because he was so slow to recover he agreed to transport to Hospital.
Isolated small red papules starting on neck and erupting over extremities over 3-4 days then no more. Itchy, some papules with small vesicles centers and several scabbed. No treatment. No fever.